Moderna (MRNA) Change in Inventory (2020 - 2026)

Moderna has reported Change in Inventory for 7 years, with the latest figure at $132.0 million in Q2 2026.

• Change in Inventory for Q2 2026 came in at $132.0 million, up 15.79% year-over-year; the trailing twelve-month figure through Jun 2026 was $38.0 million (up 124.05% YoY), and the FY2025 annual result was $34.0 million, up 140.96% from the prior year.
• Change in Inventory rose to $132.0 million in Q2 2026, from -$6.0 million in the prior quarter.
• Over five years, Change in Inventory peaked at $501.0 million in Q1 2022 and troughed at -$1.1 billion in Q4 2022.
• A 5-year average of -$64.6 million and a median of $1.0 million in 2025 frame the typical range for Change in Inventory.
• The widest annual swing landed in 2022, when Change in Inventory sank 336.97%; it then jumped 727.27% in 2025.
• A 5-year view of Change in Inventory shows it stood at -$1.1 billion in 2022, then surged by 74.73% to -$285.0 million in 2023, then fell by 2.11% to -$291.0 million in 2024, then surged by 38.49% to -$179.0 million in 2025, then surged by 173.74% to $132.0 million in 2026.
• Per Business Quant data, the three most recent Change in Inventory figures were $132.0 million in Q2 2026, -$6.0 million in Q1 2026, and -$179.0 million in Q4 2025.